Showing 121 - 140 results of 153 for search '"Neuromodulation"', query time: 0.06s Refine Results
  1. 121

    Transcutaneous vagus nerve stimulation as a pain modulator in knee osteoarthritis: a randomized controlled clinical trial by Gehad Gamal Elsehrawy, Maha Emad Ibrahim, Nermeen Hassan A.moneim, Mohamed Ahmed Hefny, Nashwa Kamel El Shaarawy

    Published 2025-01-01
    “…Conclusion There is preliminary evidence to support the benefits of tVNS in OA, suggesting that neuromodulation can be used as an adjunct to existing pharmacological and non-pharmacological treatments. …”
    Get full text
    Article
  2. 122
  3. 123

    Sensorimotor Robotic Measures of tDCS- and HD-tDCS-Enhanced Motor Learning in Children by Lauran Cole, Sean P. Dukelow, Adrianna Giuffre, Alberto Nettel-Aguirre, Megan J. Metzler, Adam Kirton

    Published 2018-01-01
    “…Exploring mechanisms of neuromodulation may advance therapeutic approaches in children with cerebral palsy and other disabilities.…”
    Get full text
    Article
  4. 124

    Repetitive Transcranial Magnetic Stimulation: Is it an Effective Treatment for Cancer Pain? by Yanyuan Du, Yaoyuan Li, Jieqing Hu, Ruiying Fang, Yuming Liu, Liu Cai, Ying Song, Susu Ma, Jin Gao, Hanyue Zhang, Baihui Li, Hongtai Xiong, Huibo Yu, Shenglei Yang, Shuduo Zhu, Honggang Zheng

    Published 2024-11-01
    “…Repetitive transcranial magnetic stimulation (rTMS), a non-invasive neuromodulation technique, shows potential in managing cancer pain. …”
    Get full text
    Article
  5. 125

    Efficacy and Safety of Transcranial Magnetic Stimulation for Attention‐Deficit Hyperactivity Disorder: A Systematic Review and Meta‐Analysis by Binbin Fu, Xiangyue Zhou, Xuan Zhou, Xin Li, Zhengquan Chen, Yanbin Zhang, Qing Du

    Published 2025-01-01
    “…ABSTRACT Background Transcranial magnetic stimulation (TMS) is a promising neuromodulation technique that has been widely used in neuropsychiatric disorders, but there was no evidence on its effect on the improvement attention‐deficit hyperactivity disorder (ADHD). …”
    Get full text
    Article
  6. 126
  7. 127

    DNMT3a Downregulation Ttriggered Upregulation of GABAA Receptor in the mPFC Promotes Paclitaxel‐Induced Pain and Anxiety in Male Mice by Lixia Tian, Xu‐Hui Li, Yu‐Long Zhao, Hui‐Yuan Yi, Xue‐Ru Liu, Rongrong Yao, Xue‐Mei Hou, Xuan Zhu, Fu‐Quan Huo, Tao Chen, Lingli Liang

    Published 2025-02-01
    “…Notably, DNA methylation undergoes adaptive changes in neurological disorders, emerging as a promising target for neuromodulation. In this study, systemic administration of PTX leads to a decrease in the expression of the DNA methyltransferase DNMT3a, while concurrently upregulating the expression of Gabrb1 mRNA and its encoded GABAARβ1 protein in the medial PFC (mPFC) of male mice. …”
    Get full text
    Article
  8. 128

    Modulation of brain activity in brain-injured patients with a disorder of consciousness in intensive care with repeated 10-Hz transcranial alternating current stimulation (tACS): a... by David Williamson, Francis Bernard, Stefanie Blain-Moraes, Caroline Arbour, Virginie Williams, Louis de Beaumont, Catherine Duclos, Béatrice P De Koninck, Daphnee Brazeau, Amelie A Deshaies, Marie-Michele Briand, Charlotte Maschke

    Published 2024-07-01
    “…Introduction Therapeutic interventions for disorders of consciousness lack consistency; evidence supports non-invasive brain stimulation, but few studies assess neuromodulation in acute-to-subacute brain-injured patients. …”
    Get full text
    Article
  9. 129

    Coupling Bio-Resonance Neurotechnology (BRNT) and Dual Hemispheric Repetitive Transcranial Magnetic Stimulation (rTMS) Reduces Comorbid Major Depressive Disorder (MDD) and Generali... by Sunder K, Makale MT, Makale M, Bodhanapati J, Murphy KT, Dennen CA, Baron D, Thanos PK, Hanna C, Ashford Jnr JW, Lewandrowski KU, Blum K

    Published 2025-02-01
    “…Keerthy Sunder,1– 3,* Milan T Makale,4,* Miles Makale,5,* Jothsna Bodhanapati,2,* Kevin T Murphy,6,* Catherine A Dennen,7,* David Baron,8,* Panayotis K Thanos,9,10,* Colin Hanna,9,* John Wesson Ashford Jnr,11,* Kai-Uwe Lewandrowski,12,* Kenneth Blum3,8,10,* 1Department of Psychiatry, University California, UC Riverside School of Medicine, Riverside, CA, USA; 2Division of Neuromodulation Research, Karma Doctors & Karma TMS, Palm Springs, CA, USA; 3Sunder Foundation, Palm Springs, CA, USA; 4Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA; 5Department of Psychology, University of California San Diego, San Diego, CA, USA; 6PeakLogic Inc., Del Mar, CA, USA; 7Department of Family Medicine, Jefferson Health Northeast, Philadelphia, PA, USA; 8Division of Addiction Research & Education, Center for Sports, Exercise and Mental Health, Western University Health Sciences, Pomona, CA, USA; 9Behavioral Neuropharmacology and Neuroimaging Laboratory On Addictions (BNNLA), Research Institute On Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA; 10Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel, Israel; 11Stanford University, Psychiatric /Public Mental Health & Population Sciences Palo Alto, Stanford, CA, USA; 12Department of Orthopaedics, Fundación Universitaria Sanitas, Bogotá D.C., Colombia*These authors contributed equally to this workCorrespondence: Kenneth Blum, Email drd2gene@gmail.comAbstract: Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) are prevalent comorbidities related to a greater likelihood of poor treatment outcomes and prolonged treatment for Reward Deficiency Syndrome (RDS) behaviors. …”
    Get full text
    Article
  10. 130

    The South African guidelines on enuresis: 2024 update by A Adam, A Badenhorst, F Claassen, T de Maayer, M Fockema, J Fredericks, E Gottlich, J John, N Lala, J Lazarus, S Leahy, H N Lourens, S Maharaj, K M Mathabe, E M Moshokoa, S B A Mutambirwa, K L Petersen, M B Radzuma, A van der Merwe, I van Heerden, C A Zietsman, F Alyami, A Deshpande, G H H Smith

    Published 2024-11-01
    “…These options include behavioural modification, urotherapy, pharmaceutical therapy, alarm therapy, alternative therapies, neuromodulation, psychological support and biofeedback. …”
    Get full text
    Article
  11. 131
  12. 132
  13. 133
  14. 134

    A Neural Correlate of Predicted and Actual Reward-Value Information in Monkey Pedunculopontine Tegmental and Dorsal Raphe Nucleus during Saccade Tasks by Ken-ichi Okada, Kae Nakamura, Yasushi Kobayashi

    Published 2011-01-01
    “…The different modulation patterns, together with the activity of dopaminergic neurons, reveal dynamic information processing between these different neuromodulator systems.…”
    Get full text
    Article
  15. 135

    The Relationship between Insecure Attachment to Depression: Mediating Role of Sleep and Cognitive Reappraisal by Yige Liu, Hongfan Li, Xiayue Xu, Yukun Li, Zhutao Wang, Huan Zhu, Xia Zhang, Shan Jiang, Naling Li, Simeng Gu, Fushun Wang, Jason H. Huang

    Published 2020-01-01
    “…Previously, we have shown that neuromodulators are important factors in stress-induced emotional disorders, such as depression, for example, serotonin is the major substance for depression. …”
    Get full text
    Article
  16. 136

    Varicella-Zoster-Mediated Radiculitis Reactivation following Cervical Spine Surgery: Case Report and Review of the Literature by Doniel Drazin, George Hanna, Faris Shweikeh, Sunil Jeswani, Leah Lovely, Richard Sokolov, John C. Liu

    Published 2013-01-01
    “…We suggest adding a neuromodulating agent to prevent long-term sequelae and resolve acute symptoms.…”
    Get full text
    Article
  17. 137

    Attentional Phenotypes for the Analysis of Higher Mental Function by John Fossella, Michael I. Posner, Jin Fan, James M. Swanson, Donald W. Pfaff

    Published 2002-01-01
    “…Next, evidence is presented showing that the operation of each network involves a dominant neuromodulator. Then we discuss development of a task designed to measure the efficiency of each network in normal individuals and consider evidence on the independence, reliability, and heritability of the networks. …”
    Get full text
    Article
  18. 138

    Cellular Signal Mechanisms of Reward-Related Plasticity in the Hippocampus by Masako Isokawa

    Published 2012-01-01
    “…I will introduce two representative neuromodulators that are widely studied in reward-related learning (e.g., ghrelin and endocannabinoids) and show how they might contribute to hippocampal neuron activities and Ca2+-mediated signaling processes in synaptic plasticity. …”
    Get full text
    Article
  19. 139

    Rapid and simple determination of histamine-N-methyl transferase activity by high-performance liquid chromatography with UV detection by Hajime Inoue, Ken-Ichi Hisamatsu, Miki Yamauchi, Norio Kumagai

    Published 2001-01-01
    “…Whether neurotransmitter or neuromodulator, the role of histamine in the brain has not yet been made clear. …”
    Get full text
    Article
  20. 140

    Cholecystokinin facilitates the formation of long-term heterosynaptic plasticity in the distal subiculum by Fengwen Huang, Abdul Baset, Stephen Temitayo Bello, Xi Chen, Jufang He

    Published 2025-02-01
    “…Nevertheless, how the neuromodulators regulate the neurocircuitry in hippocampal formation has remained elusive. …”
    Get full text
    Article